Key facts
- Poppins (Healthcare Technology Systems)’s last known valuation is $20.1M (Apr 2025).
- It has raised $22.0M; the latest was Later Stage VC ($5.4M) in Apr 2025.
- Notable investors include Techstars, Bpifrance, Verve Ventures, BNP Paribas Développement, Serena — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Poppins (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Poppins (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Poppins (Healthcare Technology Systems)
Developer of a learning digital therapeutic platform designed to improve cognitive function in children with learning disorders. The company's platform integrates neuroscience-based educational games with phonological awareness tools, offering features such as reading fluency enhancement, rhythm-based rehabilitation, and interactive exercises, enabling children with dyslexia and related challenges to achieve measurable progress in language development through engaging and structured activities.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2018
- Employees
- 50
- Website
- poppins.io/
- Ownership
- Privately Held (backing)
Poppins (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Poppins (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Poppins (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.